Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Mais filtros

Tipo de documento
Intervalo de ano de publicação
1.
Biomarkers ; 26(8): 737-746, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34634977

RESUMO

PURPOSE: Psidium guajava L. (Family, Myrtaceae) is reportedly used in ethnomedicine for the treatment of diarrhoea, inflammation, and gastroenteritis. OBJECTIVE: This study evaluated the gastrointestinal function of Psidium guajava leaf extract (PGLE) in rats and rabbits. MATERIALS AND METHODS: Crude ethanolic PGLE was subjected to phytochemical and toxicity tests (acute and sub-acute). Standard analytical procedures were employed to evaluate the in vivo gastrointestinal motility, and gastroprotective effect of PGLE against aspirin-induced ulcers. RESULTS: In the phytochemical analysis, phenols were the highest (48.32 mg) followed by flavonoids (32.74 mg) and least in tannins (7.31 mg). The acute toxicity of PGLE was >6000 mg/kg. Administration of PGLE decreased significantly (p < 0.05) the body weight, while the liver biomarkers were not significantly altered (p > 0.05) when compared to the control. PGLE significantly increased extractible mucus weight and lowered gastric acid secretion in rats (p < 0.05). PGLE decreased significantly (p < 0.05) ulcer scores and indexes, and increased percentage ulcer inhibition in a dose-dependent manner compared to the negative and omeprazole-treated groups. PGLE dose-dependently inhibited basal amplitudes of contractions, and significantly inhibited acetylcholine-induced contractions, terminating them completely at higher doses. CONCLUSION: PGLE may be a good anti-ulcer and anti-diarrhoeal agent, raising the prospect of novel drug development for such applications.


Assuntos
Diarreia/prevenção & controle , Trato Gastrointestinal/efeitos dos fármacos , Extratos Vegetais/farmacologia , Folhas de Planta/química , Psidium/química , Úlcera/prevenção & controle , Alcaloides/isolamento & purificação , Alcaloides/farmacologia , Animais , Peso Corporal/efeitos dos fármacos , Peso Corporal/fisiologia , Diarreia/patologia , Diarreia/fisiopatologia , Flavonoides/isolamento & purificação , Flavonoides/farmacologia , Motilidade Gastrointestinal/efeitos dos fármacos , Motilidade Gastrointestinal/fisiologia , Trato Gastrointestinal/fisiologia , Humanos , Fitoterapia/métodos , Extratos Vegetais/isolamento & purificação , Coelhos , Ratos Wistar , Saponinas/isolamento & purificação , Saponinas/farmacologia , Úlcera/patologia , Úlcera/fisiopatologia
2.
Nutrients ; 12(9)2020 Aug 26.
Artigo em Inglês | MEDLINE | ID: mdl-32858812

RESUMO

Picrasma quassioides is a member of the Simaroubaceae family commonly grown in the regions of Asia, the Himalayas, and India and has been used as a traditional herbal medicine to treat various illnesses such as fever, gastric discomfort, and pediculosis. This study aims to critically review the presence of phytochemicals in P. quassioides and correlate their pharmacological activities with the significance of its use as traditional medicine. Data were collected by reviewing numerous scientific articles from several journal databases on the pharmacological activities of P. quassioides using certain keywords. As a result, approximately 94 phytochemicals extracted from P. quassioides were found to be associated with quassinoids, ß-carbolines and canthinones. These molecules exhibited various pharmacological benefits such as anti-inflammatory, antioxidant, anti-cancer, anti-microbial, and anti-parasitic activities which help to treat different diseases. However, P. quassioides were also found to have several toxicity effects in high doses, although the evidence regarding these effects is limited in proving its safe use and efficacy as herbal medicine. Accordingly, while it can be concluded that P. quassioides may have many potential pharmacological benefits with more phytochemistry discoveries, further research is required to determine its real value in terms of quality, safety, and efficacy of use.


Assuntos
Medicina Tradicional/métodos , Compostos Fitoquímicos/farmacologia , Picrasma , Extratos Vegetais/farmacologia , Anti-Inflamatórios/farmacologia , Anti-Inflamatórios/uso terapêutico , Antimaláricos/farmacologia , Antimaláricos/uso terapêutico , Antineoplásicos/farmacologia , Antineoplásicos/uso terapêutico , Antioxidantes/farmacologia , Antioxidantes/uso terapêutico , Humanos , Compostos Fitoquímicos/uso terapêutico , Extratos Vegetais/uso terapêutico , Úlcera/prevenção & controle
3.
J Med Food ; 21(4): 408-415, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29216438

RESUMO

Several studies have shown the protective effect of dairy products, especially α-lactalbumin and derived hydrolysates, against induced gastric ulcerative lesions. The mucus strengthening represents an important mechanism in the defense of gastrointestinal mucosa. Previously, a hydrolysate from casein (CNH) and a hydrolysate from whey protein concentrate rich in ß-lactoglobulin (WPH) demonstrated a stimulatory activity on mucus production in intestinal goblet cells. The aim of this work was to evaluate the possible antiulcerative activity of these two hydrolysates in an ethanol-induced ulcer model in rats. All tested samples significantly reduced the ulcerative lesions index (ULI), compared with the saline solution, using doses of 300 and 1000 mg kg-1 body weight with decreases up to 66.3% ULI. A dose-response relationship was found for both hydrolysates. The involvement of endogenous sulfhydryl (SH) groups and prostaglandins (PGs) in the antiulcerative activity was evaluated using their blockage. The antiulcerative activity of WPH showed a drastic decrease in presence of N-ethylmaleimide (from 41.4% to 9.2% ULI). However, the CNH antiulcerative properties were not significantly affected. The cytoprotective effect of WPH appears to depend on a PG-mediated mechanism. In conclusion, CNH and WPH demonstrated in vivo antiulcerative properties and represent a promising alternative as protectors of the gastric mucosa.


Assuntos
Antiulcerosos/uso terapêutico , Caseínas/uso terapêutico , Mucosa Gástrica/efeitos dos fármacos , Leite/química , Hidrolisados de Proteína/uso terapêutico , Úlcera/prevenção & controle , Proteínas do Soro do Leite/uso terapêutico , Animais , Antiulcerosos/farmacologia , Caseínas/farmacologia , Etanol/efeitos adversos , Mucosa Gástrica/metabolismo , Mucosa Gástrica/patologia , Masculino , Muco/metabolismo , Hidrolisados de Proteína/farmacologia , Ratos Wistar , Úlcera/induzido quimicamente , Úlcera/metabolismo , Proteínas do Soro do Leite/farmacologia
4.
Molecules ; 24(1)2018 Dec 31.
Artigo em Inglês | MEDLINE | ID: mdl-30602714

RESUMO

A hitherto unknown polyoxygenated flavonol robinobioside (gossypetin-3-O-ß-d-robinobioside) was isolated from the leaves of Caesalpinia gilliesii along with thirteen known phenolic secondary metabolites. The isolated compounds were characterized using spectroscopic analysis, including 1D and 2D NMR and mass spectrometry (MS) analyses. The extract reduced the level of liver damage in CCl4-induced liver injury in rats. A decrease of the liver biomarkers-aspartate aminotransferase (AST) and alanine aminotransferase (ALT) and an increase of total antioxidant capacity (TAC) levels-were observed similar to the liver protecting drug silymarin. In addition, the extract showed promising activity against carrageenan-induced paw edema in rats and protected their stomachs against ethanol-induced gastric ulcers in a concentration dependent fashion. The observed activities could be attributed to the high content of antioxidant polyphenols. Our results suggest that the C. gilliesii has the capacity to scavenge free radicals and can protect against oxidative stress, and liver and stomach injury.


Assuntos
Caesalpinia/química , Edema/prevenção & controle , Flavonóis/administração & dosagem , Estresse Oxidativo/efeitos dos fármacos , Compostos Fitoquímicos/administração & dosagem , Úlcera/prevenção & controle , Alanina Transaminase/genética , Animais , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/química , Anti-Inflamatórios/farmacologia , Aspartato Aminotransferases/genética , Tetracloreto de Carbono/toxicidade , Carragenina/toxicidade , Relação Dose-Resposta a Droga , Edema/induzido quimicamente , Edema/metabolismo , Flavonóis/química , Flavonóis/farmacologia , Fígado/efeitos dos fármacos , Fígado/enzimologia , Masculino , Compostos Fitoquímicos/química , Compostos Fitoquímicos/farmacologia , Extratos Vegetais/administração & dosagem , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Ratos , Silimarina/administração & dosagem , Silimarina/química , Silimarina/farmacologia , Úlcera/induzido quimicamente
5.
Europace ; 19(3): 385-391, 2017 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-27540039

RESUMO

AIMS: Oesophageal probes to monitor luminal oesophageal temperature (LET) during atrial fibrillation (AF) catheter ablation have been proposed, but their effects remain unclear. Aim of this study is to evaluate the effects of an oesophageal temperature probe with insulated thermocouples. METHODS AND RESULTS: Patients with symptomatic, drug-refractory paroxysmal or persistent AF who underwent left atrial radiofrequency (RF) catheter ablation were prospectively enrolled. Patients were ablated using a single-tip RF contact force ablation catheter. An intraluminal oesophageal temperature probe was used in Group 1. In Group 2, patients were ablated without LET monitoring. Assessment of asymptomatic endoscopically detected oesophageal lesions (EDEL) was performed by oesophagogastroduodenoscopy (EGD) in all patients. Eighty patients (mean age 63.7 ± 10.7 years; men 56%) with symptomatic, drug-refractory paroxysmal (n = 28; 35%) or persistent AF were included. Group 1 and Group 2 patients (n = 40 in each group) were comparable in regard to baseline characteristics, but RF duration on the posterior wall was significantly shorter in Group 1 patients. Overall, seven patients (8.8%) developed EDEL (four ulcerations, three erythema). The incidence of EDEL in Group 1 and Group 2 patients was comparable (7.5 vs. 10%, P = 1.0). No major adverse events were reported in both groups. CONCLUSION: According to these preliminary results, the use of oesophageal temperature probes with insulated thermocouples seems to be feasible in patients undergoing AF RF catheter ablation. The incidence of post-procedural EDEL when using a cut-off of 39°C is comparable to the incidence of EDEL without using a temperature probe.


Assuntos
Fibrilação Atrial/cirurgia , Ablação por Cateter/efeitos adversos , Eritema/prevenção & controle , Esôfago/lesões , Monitorização Intraoperatória/instrumentação , Veias Pulmonares/cirurgia , Termômetros , Úlcera/prevenção & controle , Ferimentos e Lesões/prevenção & controle , Idoso , Fibrilação Atrial/diagnóstico , Fibrilação Atrial/fisiopatologia , Protocolos Clínicos , Técnicas Eletrofisiológicas Cardíacas , Desenho de Equipamento , Eritema/diagnóstico , Eritema/epidemiologia , Esofagoscopia , Estudos de Viabilidade , Feminino , Alemanha/epidemiologia , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Veias Pulmonares/fisiopatologia , Úlcera/diagnóstico , Úlcera/epidemiologia , Ferimentos e Lesões/diagnóstico , Ferimentos e Lesões/epidemiologia
7.
Dig Dis Sci ; 61(1): 91-8, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26423078

RESUMO

BACKGROUND/AIM: How to prevent the small intestinal damage induced by NSAIDs is an urgent issue to be resolved. In the present study, we examined the effects of soluble dietary fibers on both anti-inflammatory and ulcerogenic effects of indomethacin in arthritic rats. METHODS: Male Wistar rats weighing 180-220 g were used. Arthritis was induced by injecting Freund's complete adjuvant (killed M. tuberculosis) into the plantar region of the right hindpaw. The animals were fed a regular powder diet for rats or a diet supplemented with soluble dietary fibers such as pectin or guar gum. Indomethacin was administered once a day for 3 days starting 14 days after the adjuvant injection, when marked arthritis was observed. The volumes of the hindpaw were measured before and after indomethacin treatment to evaluate the effect of indomethacin on edema. The lesions in the small intestine were examined 24 h after the final dosing of indomethacin. RESULTS: Hindpaw volume was increased about 3 times 14 days after injection of the adjuvant. Indomethacin (3-10 mg/kg, p.o.) decreased hindpaw volume dose-dependently, but caused severe lesions in the small intestine at doses of 6 and 10 mg/kg. The addition of pectin (1-10 %) or guar gum (10 %) to the diet markedly decreased the lesion formation without affecting the anti-edema action of indomethacin. The same effects of pectin were observed when indomethacin was administered subcutaneously. CONCLUSIONS: It is suggested that soluble dietary fibers can prevent intestinal damage induced by NSAIDs without affecting the anti-inflammatory effect of these agents.


Assuntos
Anti-Inflamatórios não Esteroides/toxicidade , Artrite Experimental/tratamento farmacológico , Fibras na Dieta/administração & dosagem , Galactanos/administração & dosagem , Indometacina/toxicidade , Mucosa Intestinal/efeitos dos fármacos , Intestino Delgado/efeitos dos fármacos , Articulações/efeitos dos fármacos , Mananas/administração & dosagem , Pectinas/administração & dosagem , Gomas Vegetais/administração & dosagem , Úlcera/prevenção & controle , Animais , Artrite Experimental/induzido quimicamente , Artrite Experimental/patologia , Citoproteção , Relação Dose-Resposta a Droga , Adjuvante de Freund , Mucosa Intestinal/patologia , Intestino Delgado/patologia , Articulações/patologia , Masculino , Ratos Wistar , Solubilidade , Fatores de Tempo , Úlcera/induzido quimicamente , Úlcera/patologia
8.
Nat Prod Res ; 27(12): 1102-7, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-22712542

RESUMO

Antiulcerogenic activity of crude ethanolic extract of Celtis iguanaea leaves (CEE) was observed with experimental models such as ethanol, indomethacin, stress and pyloric ligation-induced gastric ulcers. Results obtained from indomethacin-induced ulcer showed the hexane fraction (HF) as the active fraction of CEE. This fraction inhibits the gastric acid secretion, increasing the gastric pH, decreasing the gastric acidity and total gastric contents. Neither the CEE nor the HF alters intestinal motility, thereby excluding a cholinergic antagonist mechanism. Further studies need to be conducted with HF in order to elucidate the active principle and the pharmacological mechanism involved.


Assuntos
Antiulcerosos/farmacologia , Folhas de Planta/química , Ulmaceae/química , Animais , Antiulcerosos/química , Relação Dose-Resposta a Droga , Etanol/toxicidade , Ácido Gástrico/metabolismo , Motilidade Gastrointestinal/efeitos dos fármacos , Hexanos/química , Concentração de Íons de Hidrogênio , Indometacina/efeitos adversos , Masculino , Camundongos , Extratos Vegetais/farmacologia , Plantas Medicinais/química , Substâncias Protetoras/química , Substâncias Protetoras/farmacologia , Úlcera/induzido quimicamente , Úlcera/prevenção & controle
9.
World J Gastroenterol ; 16(33): 4193-9, 2010 Sep 07.
Artigo em Inglês | MEDLINE | ID: mdl-20806438

RESUMO

AIM: To analyze the possible protective role of Arctium lappa L. (AL) in a murine model of ulcerative colitis (UC). METHODS: BALB/c mice were administered 100 mg/kg AL powder orally each day. After 7 d, colitis was induced by administration of dextran sulfate sodium (DSS) (5% W/V) in drinking water for a further 8 consecutive days. Diarrhea and bloody stools as well as colonic histology were observed. The level of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) in colonic sections were detected by immunohistochemistry. RESULTS: There were significant differences in mean body weight values and disease activity indices between controls and AL-treated animals. Moreover, the histological findings showed that AL treatment can prevent mucosal edema, submucosal erosions, ulceration, inflammatory cell infiltration and colon damage. In addition, immunohistochemistry analysis showed that the levels of the inflammatory cytokines, IL-6 and TNF-alpha were also decreased in AL-treated groups. CONCLUSION: We suggest that AL can prevent intestinal damage and decrease inflammatory cytokines in mice with DSS-induced colitis. Thus, AL could prove to be a useful food for UC.


Assuntos
Arctium , Colite Ulcerativa/induzido quimicamente , Colite Ulcerativa/tratamento farmacológico , Sulfato de Dextrana/efeitos adversos , Fitoterapia , Preparações de Plantas/uso terapêutico , Administração Oral , Animais , Colite Ulcerativa/metabolismo , Colo/metabolismo , Modelos Animais de Doenças , Edema/prevenção & controle , Interleucina-6/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Preparações de Plantas/administração & dosagem , Preparações de Plantas/farmacologia , Fator de Necrose Tumoral alfa/metabolismo , Úlcera/prevenção & controle , Redução de Peso/efeitos dos fármacos
10.
Iatreia ; 23(2): 107-118, jun. 2010. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-599249

RESUMO

La terapia larval es utilizada desde los años 30 del siglo pasado para la remoción del tejido necrótico en el tratamiento de úlceras crónicas infectadas logrando con ello promover la formación de tejido granuloso para el crecimiento de piel sana; especialmente a partir de la aparición de la resistencia a los antibióticos se la reconoce como una alternativa eficaz. Se presentan los resultados de la aplicación de la terapia larval en 42 pacientes con úlceras de diferentes orígenes, utilizando, como una nueva alternativa en larviterapia, la especie Lucilia eximia. Se presenta documentación fotográfica de la aplicación de esta terapia en cuatro casos.


Larval therapy is used in the treatment of infected chronic wounds by allowing the removal ofnecrotic tissue, which induces the formation of granular tissue and the growth of healthy skin.Considering the increasing prevalence of antibiotic resistance, this type of therapy may be an effectivealternative in the management of infected chronic wounds. In this article we report the use ofmaggot therapy using the Lucilia eximia species in 42 patients with chronic skin wounds associatedto different pathologies including: venous and arterial ulcers, diabetic foot, sickle cell disease,vasculopathy, elephantiasis, Berger disease, pyoderma gangrenosum (PG), traumatic wounds, erysipelas, and hospital acquired infections. Four cases are depicted photographically.


Assuntos
Humanos , Colômbia , Larva , Terapêutica , Úlcera/prevenção & controle
11.
Curr Pharm Des ; 16(10): 1209-13, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20166992

RESUMO

Recent advances in endoscopic techniques such as capsule endoscopy have revealed that nonsteroidal anti-inflammatory drugs (NSAIDs) often cause ulcers in the small intestine in humans, but there are few effective agents for treatment of small intestinal ulcers. Although the pathogenesis of NSAID-induced intestinal ulcer has been widely studied, dietary factors have seldom been considered. In the present review, the role of dietary fiber (DF) in the formation of NSAID-induced intestinal ulcers is discussed. In previous studies, small intestinal lesions were not observed when NSAIDs were administered to fasted rats, dogs, and cats, but were observed in conventionally-fed animals, suggesting the importance of feeding in the formation of intestinal lesions induced by NSAIDs. However, in animals fed diets containing low or no DF, indomethacin (IND) did not produce lesions in the small intestine, but did produce lesions in animals fed diets supplemented with insoluble dietary fiber (IDF, cellulose). The results suggest that IDF in the diet plays an important role in the formation of NSAID-induced intestinal lesions. On the other hand, addition of soluble dietary fibers (SDFs) such as pectin or mucin to regular diet markedly decreased NSAID-induced intestinal lesions. Thus, IDF and SDF have opposing effects on IND-induced intestinal lesions, i.e., IDF is harmful while SDF is protective. SDFs potentially represent a novel and safe means for protecting the small intestine against NSAID-induced intestinal lesions.


Assuntos
Anti-Inflamatórios não Esteroides/toxicidade , Fibras na Dieta/administração & dosagem , Enteropatias/induzido quimicamente , Enteropatias/prevenção & controle , Intestino Delgado , Úlcera/induzido quimicamente , Úlcera/prevenção & controle , Animais , Anti-Inflamatórios não Esteroides/efeitos adversos , Anti-Inflamatórios não Esteroides/farmacologia , Fibras na Dieta/efeitos adversos , Fibras na Dieta/toxicidade , Ingestão de Alimentos/efeitos dos fármacos , Motilidade Gastrointestinal/efeitos dos fármacos , Humanos , Indometacina/efeitos adversos , Indometacina/farmacologia , Indometacina/toxicidade , Enteropatias/patologia , Solubilidade , Úlcera/patologia
12.
Gut ; 58(12): 1590-6, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19060018

RESUMO

BACKGROUND: Recent advances in endoscopy have revealed that non-steroidal anti-inflammatory drugs (NSAIDs) often cause ulcers in the human small intestine. However, the mechanism of intestinal ulcer formation is still unclear. AIMS: The role of dietary fibre (DF), intestinal motility and leukotrienes (LTs) in the formation of small intestinal ulcers induced by indomethacin (IND) was investigated in cats. METHODS: Several types of diets containing DF at various percentages were given to animals twice daily during the experiment. IND was administered orally once daily after the morning meal for 3 days, and the area of mucosal lesions in the intestine was measured. Gastrointestinal motility was measured using a telemetry system in conscious cats implanted with force transducers. RESULTS: In cats fed regular dry food containing 2.8% DF, IND (3 mg/kg, p.o.) significantly increased the motility of the lower half of the small intestine and produced many severe lesions; the total lesion area was 7.7 (SEM 2.0) cm(2) (n = 5). The lesions were markedly decreased with the low-DF diet (0.4%) and increased with the high-DF diet (7.2%). The lesion area was 0.1 (SEM 0.1) cm(2) (p<0.05) and 18.2 (SEM 4.1) cm(2) (p<0.05), respectively. Supplementation with insoluble DF (6% cellulose), but not soluble DF (pectin), in the low-DF diet increased the lesion area significantly. The hypermotility and lesion formation in the small intestine induced by IND were significantly (p<0.05) inhibited by AA-861 (a 5-lipoxygenase inhibitor), pranlukast (a LT receptor antagonist) or atropine. CONCLUSIONS: Insoluble DF, intestinal hypermotility, leukotrienes and cholinergic pathways are implicated in the pathogenesis of small intestinal ulcers induced by NSAIDs.


Assuntos
Anti-Inflamatórios não Esteroides/efeitos adversos , Fibras na Dieta/efeitos adversos , Motilidade Gastrointestinal , Enteropatias/induzido quimicamente , Intestino Delgado , Úlcera/induzido quimicamente , Animais , Gatos , Dieta , Fibras na Dieta/administração & dosagem , Úlcera Duodenal/induzido quimicamente , Úlcera Duodenal/patologia , Úlcera Duodenal/fisiopatologia , Úlcera Duodenal/prevenção & controle , Ingestão de Alimentos , Feminino , Motilidade Gastrointestinal/efeitos dos fármacos , Íleo/efeitos dos fármacos , Íleo/fisiopatologia , Indometacina/farmacologia , Enteropatias/patologia , Enteropatias/fisiopatologia , Enteropatias/prevenção & controle , Antagonistas de Leucotrienos/uso terapêutico , Leucotrienos/fisiologia , Masculino , Úlcera/patologia , Úlcera/fisiopatologia , Úlcera/prevenção & controle
13.
São Paulo; s.n; s.n; 2008. 195 p. tab, graf, ilus.
Tese em Português | LILACS | ID: biblio-837289

RESUMO

Plinia edulis (Myrtaceae), espécie arbórea popularmente conhecida como cambucá, é nativa da Mata Atlântica brasileira. Apesar do emprego na medicina tradicional em diversas moléstias, incluindo distúrbios gástricos, não existem estudos relacionando as atividades biológicas e os constituintes químicos da espécie. Esta tese relata a avaliação da gastroproteção, da atividade antioxidante, da citotoxicidade e da mutagenicidade do extrato etanol/água de folhas de P. edulis e das frações. Com o objetivo de correlacionar os metabólitos secundários com a eficácia da droga vegetal na medicina tradicional, o extrato foi submetido à partição e posterior fracionamento cromatográfico. O extrato apresentou atividade gastroprotetora significativa em modelo de indução de úlceras por etanol acidificado em ratos em doses de 100, 200 e 400 mg/kg via oral, sendo mais ativo que o fármaco de referência lansoprazol. Entre as frações, a hexânica (100 mg/kg p.o.) foi a mais eficaz, mas apresentou menor atividade do que o extrato bruto. A gastroproteção do ácido ursólico também foi avaliada, mas embora outros triterpenos sejam conhecidos como gastroprotetores, o ácido ursólico (50 mg/kg p.o.) reduziu a área lesionada, mas não apresentou atividade significativa no modelo empregado. O extrato não evidenciou mutagenicidade na concentração de 20 mg/placa no Ensaio de Ames e apresentou atividade antioxidante pronunciada, com CE50 de 5,75 µg/mL no ensaio com DPPH e valor de ORAC de 3.948 µmol de Trolox/g de extrato. O extrato e as frações foram avaliados quanto à citotoxicidade em linhagens de células tumorais humanas de UACC62 (melanoma), MCF-7 (mama), NCI 460 (pulmão), OVCAR03 (ovário), PC-03 (próstata), HT-29 (cólon), 786-0 (rins), NCI-ADR (mama com fenótipo de resistência a múltiplos fármacos) e linhagem de células normais de ovário de hamster chinês (CHO) in vitro. O extrato e as frações apresentaram citotoxicidade seletiva dose-dependente em células cancerígenas e atividade proliferativa em células normais. A partir das frações de hexano e acetato de etila foram identificados ß-amirina, lupeol, ß-sitosterol, ácido oleanólico, ácido ursólico, ácido maslínico, ácido corosólico, galato de etila, ácido gálico, quercitrina, miricitrina e quercetina por meio de análises espectrométricas. Estes resultados dão suporte à utilização popular desta espécie e estão provavelmente associados à presença dos flavonóides e triterpenos identificados no extrato


Plinia edulis (Myrtaceae), an arboreous species popularly known as cambucá, is native in Brazilian Atlantic Rain Forest. Despite its traditional uses in many diseases, which include gastric disorders, no reports are available on the relationship between the biological activities of its extract and its chemical constituents. This thesis reports the evaluations of the the aqueous ethanol extract of leaves of P. edulis and its fractions on gastroprotective effect, antioxidant capacity, cytotoxicity and mutagenicity of. In order to correlate the secondary metabolites and the efficacy of the crude drug in traditional medicine, the extract was submitted to solvent partition followed by chromatographic fractionation. The extract exhibited significant gastroprotective effect on HCl/ethanol-induced ulcers in rats at doses of 100, 200 and 400 mg/kg p.o., even more active than the reference drug lansoprazole. Among the fractions, the hexane fraction (100 mg/kg p.o.) was the most effective, but showed lower activity than the crude extract. In addition, the gastroprotective effect of ursolic acid was evaluated. Although others triterpenes are well known as gastroprotective agents, ursolic acid (50 mg/kg p.o.) reduced the lesion area, but did not show significant activity on this model. The extract did not show mutagenicity at the concentration of 20 mg/plate in the Ames test and exhibited high antioxidant activity, with EC50 of 5.75 µg/mL on the DPPH assay and ORAC value of 3948 µmol Trolox/g of extract. The extract and its fractions were evaluated for cytotoxic activity against human tumour cell lines as UACC62 (melanoma), MCF-7 (breast), NCI 460 (lung, non-small cells), OVCAR03 (ovarian), PC-03 (prostate), HT-29 (colon), 786-0 (renal), NCI-ADR (breast expressing phenotype multiple drugs resistance) and CHO (Chinese Hamster Ovary) normal cell line in vitro. The extract and its fractions showed selectively dose-dependent cytotoxicity against cancer cells and proliferative activity in normal cells. The hexane and ethyl acetate fractions yielded ß-amyrin, lupeol, ß-sitosterol, oleanolic acid, ursolic acid, maslinic acid, corosolic acid, ethyl gallate, gallic acid, quercitrin, myricitrin and quercetin, which were identified based on spectrometric analyses. These results provide scientific support to the traditional use of this species, which are probably associated with the flavonoids and triterpenoids identified in the extract


Assuntos
Myrtaceae/anatomia & histologia , Compostos Fitoquímicos/efeitos adversos , Triterpenos , Úlcera/prevenção & controle , Flavonoides , Produtos Biológicos/análise , Citotoxicidade Imunológica , Antagonistas dos Receptores H2 da Histamina , Antioxidantes
14.
Phytother Res ; 21(6): 523-30, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17380554

RESUMO

In the present study, the phytoprotective effects of gypenosides from Gynostemma pentaphyllum throughout the gastrointestinal tract and kidney were examined in indomethacin-treated rats. Indomethacin induced gastric and intestinal damage as well as renal toxicity after a single toxicological dose (10 mg/kg) in rats. Acute oral administration of the gypenoside extract (200 mg/kg) significantly reduced gastric and intestinal toxicity induced by indomethacin as measured by ulceration, caecal haemoglobin and plasma haptoglobin. A significant decrease in small intestinal lactose fermenting enterobacteria was evident in animals treated with indomethacin and those pre-treated with G. pentaphyllum then indomethacin. In the renal system, kidney toxicity was evident after indomethacin and in animals pre-treated with indomethacin plus G. pentaphyllum with an increase in urinary N-acetyl-beta-glucosaminidase and a decrease in urinary sodium and chloride electrolyte output. However, a significant increase in urinary microprotein in indomethacin-treated animals was not present in indomethacin plus G. pentaphyllum-treated animals. These studies demonstrate the efficacy of Gynostemma pentaphyllum in lowering gastrointestinal damage induced by indomethacin. The results suggest further investigations of Gynostemma gypenosides are warranted to examine the mechanisms of this phytoprotective activity.


Assuntos
Trato Gastrointestinal/efeitos dos fármacos , Indometacina/toxicidade , Rim/efeitos dos fármacos , Acetilglucosaminidase/metabolismo , Administração Oral , Animais , Cromatografia em Camada Fina , Relação Dose-Resposta a Droga , Enterobacteriaceae/efeitos dos fármacos , Enterobacteriaceae/crescimento & desenvolvimento , Trato Gastrointestinal/patologia , Gynostemma , Haptoglobinas/metabolismo , Intestino Delgado/efeitos dos fármacos , Intestino Delgado/microbiologia , Rim/patologia , Masculino , Fitoterapia , Extratos Vegetais/administração & dosagem , Extratos Vegetais/farmacologia , Ratos , Ratos Sprague-Dawley , Úlcera/induzido quimicamente , Úlcera/prevenção & controle
15.
Phytother Res ; 21(6): 517-22, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17326041

RESUMO

Baccharis trimera (Asteraceae) and Davilla rugosa (Dilleniaceae) are used popularly as tonics, aphrodisiacs and for stomach ailments, among other uses. Hydroalcohol extracts of the aerial parts of both plants were investigated with regard to their chemical constitution and their pharmacological activity in tests that evaluate adaptogen activity. Alkaloids, flavonoids, saponins, polyphenols/tannins and coumarins were identified in both extracts, while lignans were found only in the extract of Davilla rugosa. This extract presented also a marked antioxidant activity and exerted a moderate antiulcer effect in rats submitted to cold immobilization stress. It did not, however, inhibit the increase in the levels of ACTH and corticosterone induced by stress. Moreover, the Davilla rugosa did not improve the physical performance of mice submitted to forced exercise and the learning time of old rats in the T-maze, neither did it reduce the blood viscosity of the old animals. Conversely, the Baccharis trimera extract only presented a moderate antioxidant activity, without any positive effect on the other tests. These results point to the absence of an adaptogen activity of Baccharis trimera, with some effects that could be related to such an activity as regards the Davilla rugosa.


Assuntos
Antioxidantes/química , Baccharis/química , Dilleniaceae/química , Extratos Vegetais/química , Hormônio Adrenocorticotrópico/metabolismo , Alcaloides/química , Animais , Antioxidantes/farmacologia , Viscosidade Sanguínea/efeitos dos fármacos , Corticosterona/metabolismo , Cumarínicos/química , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Flavonoides/química , Lignanas/química , Aprendizagem em Labirinto/efeitos dos fármacos , Camundongos , Atividade Motora/efeitos dos fármacos , Fenóis/química , Componentes Aéreos da Planta/química , Extratos Vegetais/farmacologia , Polifenóis , Ratos , Ratos Wistar , Saponinas/química , Estresse Fisiológico/fisiopatologia , Taninos/química , Úlcera/fisiopatologia , Úlcera/prevenção & controle
16.
J Ethnopharmacol ; 87(2-3): 169-74, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12860303

RESUMO

The effect of three new derivatives from dehydrocrotonin (DHC-compound I) on gastric damage in different animal models including gastric ulceration induced by a necrotic agent and hypothermic restrained-stress was studied: compound II (produced by reducing the cyclohexenone moiety of DHC with NaBH(4)); compound III (produced by reducing the carbonyls with LiAlH(4)); and compound IV (produced by transforming the lactone moiety into an amide). Their structures were confirmed on the basis of chemical and physicochemical evidence. When previously administered (p.o.) at a dose of 100mg/kg, compound II significantly (P<0.01) reduced gastric injury induced by HCl/ethanol (78%) and indomethacin (88%) better than did reference compound I (48 and 43%, respectively). But the anti-ulcerogenic activity of compound II was completely abolished by the stress-induced ulcer. Reduction of carbonyls with LiAlH(4) (compound III) caused decreased activity, markedly when no protective effect in any of the models was applied (P>0.05). However, compound IV, in which the lactone moiety was changed into an amide, when administered at the same dose (100mg/kg, p.o.), was more effective. The presence of a lactone moiety or Michael acceptor is probably essential for the anti-ulcerogenic effect of these compounds.


Assuntos
Antiulcerosos/uso terapêutico , Croton/química , Diterpenos/uso terapêutico , Lactonas/uso terapêutico , Fitoterapia , Preparações de Plantas/uso terapêutico , Animais , Antiulcerosos/isolamento & purificação , Diterpenos/isolamento & purificação , Diterpenos Clerodânicos/química , Diterpenos Clerodânicos/uso terapêutico , Etanol , Ácido Clorídrico , Hipotermia , Indometacina , Lactonas/isolamento & purificação , Masculino , Camundongos , Casca de Planta/química , Estresse Psicológico/complicações , Relação Estrutura-Atividade , Úlcera/tratamento farmacológico , Úlcera/etiologia , Úlcera/prevenção & controle
17.
J Am Vet Med Assoc ; 220(1): 74-9, 2002 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-12680452

RESUMO

OBJECTIVE: To determine the effects of a commercially available orally administered antacid agent containing aluminum hydroxide and magnesium hydroxide on abomasal luminal pH in clinically normal milk-fed calves. DESIGN: Randomized trial. ANIMALS: 5 male dairy calves. PROCEDURE: Throughout the study, calves were fed milk replacer at 7:30 AM and 7:30 PM. Cannulae for pH electrodes were placed in the abomasal body and pyloric antrum. Treatments consisted of oral administration of a high (50 ml) or low (25 ml) dose of the antacid agent and oral administration of milk replacer alone (control). Antacid was given at 7:30 AM, 3:30 PM, and 11:30 PM, and luminal pH was monitored continuously for 24 hours, beginning 15 minutes before administration of the first dose of antacid. RESULTS: Administration of the first dose of antacid at the time of the morning feeding resulted in an increase in mean abomasal body luminal pH of < 1 pH unit, whereas administration of the second and third doses of the antacid caused transient (< 3 hours) increases in mean luminal pH of approximately 1.5 (low dose) and 2.5 (high dose) pH units. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that clinically normal milk-fed calves given a commercially available antacid agent, PO, will have a transient increase in abomasal luminal pH. Such agents may, therefore, have a role in the treatment of abomasal ulceration in calves; however, the long-term effects of orally administered antacid agents in milk-fed calves and the clinical efficacy of such agents in treating abomasal ulceration remain to be determined.


Assuntos
Abomaso/efeitos dos fármacos , Hidróxido de Alumínio/farmacologia , Antiácidos/farmacologia , Bovinos/metabolismo , Hidróxido de Magnésio/farmacologia , Abomaso/química , Administração Oral , Hidróxido de Alumínio/administração & dosagem , Animais , Animais Recém-Nascidos , Antiácidos/administração & dosagem , Doenças dos Bovinos/prevenção & controle , Concentração de Íons de Hidrogênio/efeitos dos fármacos , Hidróxido de Magnésio/administração & dosagem , Masculino , Distribuição Aleatória , Fatores de Tempo , Úlcera/prevenção & controle , Úlcera/veterinária
18.
J Pediatr Gastroenterol Nutr ; 32(3): 270-3, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11345174

RESUMO

BACKGROUND: The objective of the study was to determine whether ursodeoxycholic acid (Ursodiol) is protective against ibuprofen (IBU)-induced enteropathy. METHODS: Using the chronically catheterized rat model, IBU (60 mg/kg body weight per day) was infused via the gastric catheter twice daily. Pancreatic enzyme (PE; 10,000 U lipase/kg body weight per day) and Ursodiol (10 mg/kg body weight per day) in two doses were infused via the duodenal catheter. Rats were assigned to one of six treatment groups and were administered treatment for 20 days: control, IBU, PE, IBU + PE, IBU + Ursodiol, and IBU + PE + Ursodiol. The entire jejunum, ileum, cecum, and colon were available for histologic analysis using previously described techniques. RESULTS: Addition of Ursodiol to high-dose IBU and normal doses of PE showed a significant reduction in the percentage of rats with ulcers (P < 0.05), total number of serositis events (P < 0.01), total number of severe ulcers (P < 0.001), and an absence of ulcers in the large intestine. CONCLUSIONS: Ursodiol, the drug of choice for the treatment of cystic fibrosis liver disease, may offer a safe method of using high-dose IBU in these patients by ameliorating the enteropathy.


Assuntos
Anti-Inflamatórios não Esteroides/toxicidade , Colagogos e Coleréticos/uso terapêutico , Ibuprofeno/toxicidade , Enteropatias/induzido quimicamente , Ácido Ursodesoxicólico/uso terapêutico , Animais , Anti-Inflamatórios não Esteroides/administração & dosagem , Cateterismo , Fibrose Cística/complicações , Fibrose Cística/tratamento farmacológico , Modelos Animais de Doenças , Ibuprofeno/administração & dosagem , Enteropatias/prevenção & controle , Intestinos/efeitos dos fármacos , Intestinos/patologia , Lipase/administração & dosagem , Masculino , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Serosite/induzido quimicamente , Serosite/prevenção & controle , Úlcera/induzido quimicamente , Úlcera/prevenção & controle
19.
Rev. paul. acupunt ; 5(1): 12-6, jan.-jun. 1999. tab, graf
Artigo em Português | LILACS | ID: lil-254167

RESUMO

Desde tempos remotos o homem utiliza-se do calor para a analgesia e cura de doenças. A aplicação de moxabustão constitui terapêutica coadjuvante no tratamento com acupuntura, cujo princípio básico consiste em aquecer os pontos de acupuntura, pela combustão da erva Artemisia vulgaris. Objetivo - Avaliar o efeito da aplicação de moxabustão nos pontos de acupuntura E-25 (Tianshu), E-36 (Zusanli), VC-12 (Zhongwan), na prevenção de lesões agudas da mucosa gástrica produzidas pela indometacina, em ratos Wistar. Material - 30 ratos Wistar, fêmeas adultas, de peso 165 a 215g. Método - Os animais foram mantidos em jejum com acesso livre à água por 24h e aleatoriamente divididos em três grupos. Todos os ratos foram submetidos à anestesia superficial com éter e receberam indometacina (20mg/kg de peso) por cateterização orogástrica e, em seguida, imobilizados. O grupo I (INDO) foi apenas imobilizado por 6 minutos. O grupo II (MOXA) foi imobilizado e submetido à aplicação de moxabustão nos pontos E-25 (Tianshu), E-36 (Zusanli), VC-12 (Zhongwan), por 1'40''em cada ponto, respectivamente. O grupo III (SHAM) foi imobilizado e submetido à aplicação de moxabustão por 1'40'' em cada uma de cinco regiões de não ponto de acupuntura. Resultados. - Os resultados submetidos ao teste de estatística de análise de variância por postos de Kruskal-Wallis, complementado pelo teste de comparações múltiplas, mostraram que o grupo Moxa apresentou 59 por cento menos lesões que o grupo INDO, comprovando estatisticamente a eficácia da terapêutica por aplicação de moxabustão na prevenção de lesões agudas da mucosa gástrica produzidas pela indometacina em ratos Wistar. O grupo SHAM apresentou 40 por cento menos lesões que o grupo INDO, demonstrando que a aplicação de moxabustão em não ponto, também, apresenta algum efeito, embora reduzido, estatisticamente significante. Conclusão - Foi comprovado estatisticamente que a terapêutica com moxabustão é eficaz na prevenção de lesões agudas da mucosa gástrica produzidas pela indometacina em ratos.


Assuntos
Animais , Feminino , Ratos , Pontos de Acupuntura , Terapia por Acupuntura , Indometacina/efeitos adversos , Acupuntura , Anti-Inflamatórios/efeitos adversos , Mucosa Gástrica/patologia , Úlcera/induzido quimicamente , Úlcera/prevenção & controle , Fatores de Tempo , Resultado do Tratamento , Ratos Wistar , Temperatura Alta , Doença Aguda
20.
Yakugaku Zasshi ; 115(10): 852-62, 1995 Oct.
Artigo em Japonês | MEDLINE | ID: mdl-8531064

RESUMO

Pharmacological effects on anti-diuresis, anti-ulceration, anti-dementia and learning function of 50% ethanolic extract (AO-ext) from Alpiniae Fructus (fruit of Alpinia oxyphylla) removed seed vessel were investigated in order to prove the evidence of the efficacy of Alpiniae Fructus on the ancient herbal literature. AO-ext showed the effects of anti-diuresis, anti-ulceration, anti-dementia and on increase in the learning function in animals. And also, AO-ext exhibited the increasing effect on the serum 11-hydroxycorticosteroid (11-OHCS) level in the above-described experimental animals and in intact and hypophysectomized rats.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , 11-Hidroxicorticosteroides/sangue , Animais , Demência/prevenção & controle , Diurese/efeitos dos fármacos , Medicamentos de Ervas Chinesas/uso terapêutico , Gerbillinae , Aprendizagem/efeitos dos fármacos , Masculino , Ratos , Ratos Wistar , Úlcera/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA